Ipca Laboratories is currently trading at Rs. 653.20, down by 11.45 points or 1.72% from its previous closing of Rs. 664.65 on the BSE.
The scrip opened at Rs. 660.00 and has touched a high and low of Rs. 673.90 and Rs. 650.05 respectively. So far 160227 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 899.30 on 30-Jun-2014 and a 52 week low of Rs. 591.25 on 09-Feb-2015.
Last one week high and low of the scrip stood at Rs. 798.00 and Rs. 650.05 respectively. The current market cap of the company is Rs. 8256.58 crore.
The promoters holding in the company stood at 45.89% while Institutions and Non-Institutions held 34.72% and 19.38% respectively.
IPCA Laboratories has got import alert from US Food and Drug Administration (USFDA) for two of its manufacturing plants. According to USFDA, IPCA Labs' unit in Pithampura (MP) and Piparia (Silvassa) have failed to meet GMP.
This is the third import alert for the company. Earlier in January this year, US regulator had banned imports from a Madhya Pradesh manufacturing plant of Ipca, citing violations of standard production practices.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |